Items Tagged ‘David Nagorney’
November 29, 2022
Predicting pancreatic cancer outcomes prior to surgery
By Advancing the Science contributor 
By Chloe Corey Pancreatic cancer is considered one of the least survivable forms of cancer. However, in new research published in Journal of the National Comprehensive Cancer Network, Mayo Clinic investigators demonstrated a way to predict long-term survival outcomes with high accuracy prior to surgery for patients diagnosed with borderline resectable or locally advanced pancreatic […]
Tags: Ajit Goenka, Amro Abedelrahman, Christopher Hallemeier, Cornelius Thiels, CT, David Nagorney, Jennifer Leiting, Jennifer Yonkus, Kenneth Merrell, Mark Truty, Mayo Clinic Cancer Center, Michael Haddock
November 10, 2015
CA 19-9 tumor marker test especially important for early-stage patients, Mayo finds Only 1 in 5 U.S. pancreatic cancer patients receive a widely available, inexpensive blood test at diagnosis that can help predict whether they are likely to have a better or worse outcome than average and guide treatment accordingly, a Mayo Clinic study shows. […]
Tags: Carlos Puig, Center for the Science of Health Care Delivery, Christopher Shubert, David Nagorney, Elizabeth Habermann, John (Jay) Bergquist, Mark Truty, Michael Farnell, Michael Kendrick, pancreatic cancer, Rory Smoot, Ryan Groeschl